chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received the vaccine at about 2:15 pm, and that night my arm hurt quite a lot and I had a hard time sleeping. I felt OK the next morning though. At my desk at work 24 hours after I received the vaccine, I felt very ill. It came on pretty suddenly. I had a headache and extreme chills, and felt like I had a bad flu. I was slightly nauseous. I spent 6 1/2 hours lying on my office floor, only getting up to use the restroom. I felt unsafe to drive home. I stayed home from work for the next 2 days. My arm is still hard and hurts quite a bit 77 hours after the vaccination. I was never warned that many patients have a reaction like this, where they are unable to conduct their normal activities. I think medical personnel should be trained to explain this to people so that we can take this into consideration when scheduling the vaccination.
Pt states inject site started hurting next day was reddened x 2 wks; has dull pain to lt arm which radiates to hand; states can't move arm up in a fast motion; arm hurts more @ noc; states was given pain meds;
From initial information received on 29/Jun/2005 from a physician regarding an adverse event occurring in the USA, it was reported that a 6 month old male pt received a third dose of ActHIB, lot number UE420AA (alternate lot number X1250-2), administered IM in the left thigh and a third dose of Daptacel, lot number C1398AA, administered IM in the right thigh at 5 PM on 18/Jan/2005. Fifteen hours post-vaccination, during the morning of 19/Jan/2005 and again on 31/Jan/2005 the pt experienced additional seizure. The pt was admitted to the hospital and discharged home on 01/Feb/2005. The pt then experienced his 4th seizure on an unspecified date and was admitted to another hospital. A CT Scan, metabolic work up, MRI and two video EEGs were normal. On 11/Feb/2005, the pt was diagnosed with partial epilepsy. In May 2005, a neurologist diagnosed the pt with epilepsy. The pt's past medical history is significant for a contusion suffered in September 2004 after he was dropped from a car seat by his sister. One of his parents has a past medical history of seizure disorder. Per the pt's parent he has a past medical history of seizure disorder. Per the physician that pt had no adverse events following previous doses of Daptacel at two and four months of age. There is no history of neurological symptoms in the pt's siblings following vaccination. As per the reporting physician, it is her medical opinion that the vaccine did not cause the seizure, but probably brought an underlying condition to the surface. The pt's recovery status is currently unknown. From additional information received on July 2008, it was reported that the Trileptal and Diastat suppositories were prescribed by the attending physician at the time of the event and the patient remains on these medications. 13/Jul/2005: During internal review of this case, it was noted that this patient had also received a first dose of , lot number 20240, in December 2004. The exact date was not specified. This information was previously captured in the product section but not included in the narrative.
This unconfirmed spontaneous report as received from a pharmacist and from a nurse refers to an unspecified number of patients of unknown age (reported as 13 years of age or older) and gender. No information regarding the patients' medical history or concurrent conditions was provided. The pharmacist reported that the nurse told him that on unknown dates, the unspecified patients, aged 13 or older, were vaccinated with doses of (Oka/Merck) PROQUAD injection (dose, route of administration, lot# and expiry date were not reported) by unspecified healthcare providers. There were no concomitant therapies reported. No adverse symptoms were reported. There was no product quality complaint involved. Additional information is not expected as the reporter declined consent for follow-up.
Began Feb. 20, 2021 to have pain, itching and pressure in left ear canal and inner left ear to the point that I saw and ENT.  He said it was wax.  The symptoms persisted and I ended up seeing a second ENT, Dr.  as well as my family physician.
After vax was given, patient came in the next day she had developed a red bump on her left thigh. Pt was seen by Dr.
Sore throat and tactile temperature 1 day after admin and resolution of this but onset of 8 x 15 cm area of redness, warmth and swelling around injection sit eon 2nd & 3rd days after injection- (Today is 3rd day after injection)
Pt went to ER on 6/6/17 at 9:26 pm with complaints of redness and swelling of right upper arm. Diagnosed with cellulitis of right upper arm. Given Cephalexin 500 mg, 4 times a day for 7 days.
the patient had a swollen armpit/lymphnode area after receiving the moderna vaccine. he said it was painful (likely due to the swelling and location) and has only just started to go down after the 3rd day. i instructed him to follow up with his doctor and determine what course of therapy and whether or not to complete the series.
tested positive for the Covid virus a week later/she was asymptomatic; This is a spontaneous report received from a contactable healthcare professional (patient) via a Pfizer-sponsored program. A 40-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number was not reported), via an unspecified route of administration, administered in left arm on 16Apr2021 08:00 (at the age of 40-year-old) as 1st dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had no history of all previous immunization with the Pfizer vaccine considered as suspect. The patient received the first dose of the Pfizer Covid-19 vaccine and tested positive for the Covid virus on 23Apr2021. She was scheduled to receive her second dose on 07May2021, and they said because she was asymptomatic, some people said she would be fine, some people said wait, nobody gave her a straight answer. She is asking when she can receive her second dose. She is a little apprehensive and wasn't sure on when to receive the second dose due to hearing numerous things. She plans to receive the second dose this week. On 23Apr2021, the patient tested positive for COVID. The patient recovered from the event on unspecified date.  Information on the lot/batch number has been requested.
With the second dose she also got the lump in the injection arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (With the second dose she also got the lump in the injection arm) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 008B21) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced VACCINATION SITE MASS (With the second dose she also got the lump in the injection arm). At the time of the report, VACCINATION SITE MASS (With the second dose she also got the lump in the injection arm) outcome was unknown.            Concomitant information was not reported. Treatment information was not reported.   This case was linked to MOD-2021-374515 (Patient Link).
Nothing reported Follow up received on Jan 08 2010 - Please disregard the report that was filled out this was done in error and there was no reaction.
Exactly 12 hours after receiving the shot, I had chills and body aches and extreme headache. For the next 30 hours, I rotated between chilling and feverish, with 100.3 temp,  with constant body aches and headache.  Now after all those symptoms have resolved, my left arm is very sore and hard to raise.
Eight days after vaccine was administered, the patient developed redness, swelling, tenderness and itching in the same arm.  The area involved was approximately 8cm x 10cm.  Symptoms worsened over 24-36 hours and have been gradually subsiding.  Not yet entirely resolved.
Swollen and painful lymph nodes armpit; Painful lymph nodes armpit; Booster dose; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non pregnant female patient received third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2590) via an unspecified route of administration in the left arm on 27Oct2021 at 15:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. It was not reported if the patient received any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 22Mar2021 (at the age of 46-years-old) as a single dose for COVID-19 immunisation and also the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 12Apr2021 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. On 28Oct2021 at 04:00, the patient experienced swollen and painful lymph nodes in armpit. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events swollen and painful lymph nodes armpit was not resolved at the time of this report.
felt like everything was inflamed; guts hurt; chest kind of felt weird but not too alarming; ear clogged/ear felt like there is pressure behind it; felt like if holding nose and blowing; joints hurt; 101.6 fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt like everything was inflamed), GASTROINTESTINAL PAIN (guts hurt), CHEST DISCOMFORT (chest kind of felt weird but not too alarming), EAR DISCOMFORT (ear clogged/ear felt like there is pressure behind it) and NASAL DISCOMFORT (felt like if holding nose and blowing) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012H21B, 038A21A and 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Blood pressure high.On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form.On 23-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (felt like everything was inflamed), GASTROINTESTINAL PAIN (guts hurt), CHEST DISCOMFORT (chest kind of felt weird but not too alarming), EAR DISCOMFORT (ear clogged/ear felt like there is pressure behind it), NASAL DISCOMFORT (felt like if holding nose and blowing), ARTHRALGIA (joints hurt) and PYREXIA (101.6 fever). At the time of the report, FEELING ABNORMAL (felt like everything was inflamed), GASTROINTESTINAL PAIN (guts hurt), CHEST DISCOMFORT (chest kind of felt weird but not too alarming), EAR DISCOMFORT (ear clogged/ear felt like there is pressure behind it), NASAL DISCOMFORT (felt like if holding nose and blowing), ARTHRALGIA (joints hurt) and PYREXIA (101.6 fever) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available):On an unknown date, Heart rate increased: high (High) resting heart rate was high like 85 after sitting when normally it's 60.Concomitant medications were not reported. Patient checked blood pressure today and noticed resting heart rate was high like 85 after sitting when normally it's 60. He was not taking any medication after experiencing any of the symptoms. He had never tested positive for Covid. He had no medical history of heart issues but had high blood pressure a year a go from licorice tea.This case was linked to MOD-2021-406577, MOD-2021-406572 (Patient Link).
5 min after shot was given:  warmth, nausea, dizzy, feeling of passing out, throat closing up, pins and needles in face and fingers/hands/forearms, red face and chest, and weakness.   Second day,  nausea, stomach cramps, dizziness.
Expired Kinrix administered; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 8-year-old male patient who received DTPa-IPV (Kinrix) (batch number YZ97N, expiry date 26th August 2022) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 30th September 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 30th September 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 03-OCT-2022 Reporter's Comment: The registered nurse reported that a dose of Kinrix given to the patient and it was already expired.  The reporter did not consent to follow up.  The Vaccine Administration Facility was the same as primary reporter. Additional Supportive Information: The use of Kinrix dose, which was already expired on 26th August 2022, which led to expired vaccine used.
The pain was significant, but not only that she could not lift the arm/It stung /when touched it hurts/it still hurts where shot was placed; The pain was significant, but not only that she could not lift the arm/It stung /when touched it hurts/it still hurts where shot was placed; she could not lift the arm; it's red and extends down arm; red marks going through her biceps and can see red areas; it's red and extends down arm; red marks going through her biceps and can see red areas; Had received Prevnar 13 already when in (city name) more than 2 years ago before moving here/received a shot of Prevnar 13, the second dose this Sat, 29; This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received the second dose of  pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration to left arm on 29Aug2020 at single dose for routine vaccination, influenza vaccine (FLU), via an unspecified route of administration to left arm on 29Aug2020 at unknown dose for routine vaccination. Medical history included hypothyroidism from Feb1999 and ongoing. The patient's concomitant medications were not reported. The patient previously received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) for immunization more than 2 years ago. The patient reported that she received a shot of Prevnar 13, the second dose this Saturday, 29Aug2020. The pain was significant, but not only that she could not lift the arm on 29Aug2020. It stung and it's red and that had extended down to her arm and when touched it hurts on 29Aug2020. That shot was really bad and she believed it was worse than the Shingles vaccine she had more than a month ago. Unable to provide any product details (NDC, Lot, or expiry) for the Shingles vaccine, but received that at the Pfizer infirmary. The arm had gotten better when lifting the arm, it still hurts where shot was placed. Had red marks going through her biceps and can see red areas and mentioned again it hurts when touched. In addition to getting the Prevnar 13 she had the flu shot as well that day and never experienced this with the flu shot. She had received Prevnar 13 already when in (city name) more than 2 years ago before moving here. The patient underwent lab tests and procedures which included comprehensive metabolic panel, CBC with differential, urine, TSH, free T4, lipids,  and vitamin D; all on 28Aug2020 with result of normal. The outcome of event "she could not lift the arm" was resolving, outcome of other events was not resolved.   Information on the lot/batch number has been requested.
Date of Admission: 10/21/2022   Date of Discharge: 10/28/2022   Admission Diagnosis: Hyponatremia COVID 19   Hospital Principal Problem (Discharge Diagnoses): COVID-19
Fever as high as 103.1; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included MMR (MMR vaccine) for prophylaxis.   On 2nd May 2022, the patient received Shingrix and MMR vaccine. In May 2022, 12 hrs after receiving Shingrix and MMR vaccine, the patient experienced fever. The patient was treated with ibuprofen (Motrin). On an unknown date, the outcome of the fever was recovering/resolving.   It was unknown if the reporter considered the fever to be related to Shingrix and MMR vaccine.     Additional Information: GSK Receipt Date: 03-May-2022 Reporter's Comments: This case was reported by a patient via interactive digital media. The patient received the Shingrix vaccine with the MMR a day before reporting and developed a fever about 12 hours after vaccination. The patient stated that it had been as high as 103.1, the patient took Motrin and the fever was then 101. The patient wanted to know if it was normal. Additional Supportive Information: The follow-up would not be possible as no contact details were available.
Light headedness; scratchy voice; itchy eyes and throat; itchy eyes and throat; pink and hot swollen circular hive/welt underneath injection site on left arm; pink and hot swollen circular hive/welt underneath injection site on left arm; This is a spontaneous report from a non-contactable other healthcare professional, the patient.  A 41-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 20Jan2021 at 07:30 (at the age of 41 years old) as a single dose in the left arm for COVID-19 vaccination.  Medical history included seasonal allergies from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination, but did receive the first dose of  BNT162B2, on 31Dec2020 in the left arm. On 21Jan2021 at 09:30, the patient experienced  light headedness, scratchy voice, itchy eyes and throat, pink and hot swollen circular hive/welt underneath injection site on left arm. The patient did not receive treatment for the events. The clinical outcome of  light headedness, scratchy voice, itchy eyes and throat, pink and hot swollen circular hive/welt underneath injection site on left arm was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
SEVERE PAIN IN TEMPLE; VOMITING; ACHINESS; CHILLS; FEVER; This spontaneous report received from a consumer concerned a 19 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 40z1AZ1A, expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 11:00 for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021, the subject experienced fever. On 06-APR-2021, the subject experienced severe temple pain. On 06-APR-2021 03:00, the subject experienced vomiting. On 06-APR-2021 03:00, the subject experienced achiness. On 06-APR-2021 03:00, the subject experienced chills. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vomiting, achiness, chills, fever, and severe temple pain on 06-APR-2021 13:00. This report was non-serious.
Extreme shoulder pain migrating into neck.  Unable to perform normal tasks using right hand/arm due to extreme pain and limited range of motion.
Superficial thrombophlebitis of right basilic vein. resolved with anti-inflammatory.
Patient received Moderna vaccine on 3/19/21 at another facility Patient received Pfizer vaccine on  06/25/21 and 07/16/21 here.  It was recommended by his specialist that he restart the series
Received 1st dose at 3pm on 7/7/21.  Observed by facility staff for 30 minutes.  Felt fatigued, but otherwise no symptoms.  On 7/8/21 at 7:45am went for a run outside.  Mid-run felt generalized, severe itching and swelling in throat and facial swelling.  Returned home within minutes, reported symptoms to me (mom).  Called 911.  Epi-Pen 0.3mg injection given in  right thigh with no effect.  Three minutes later, another Epi-Pen 0.3mg injection given in left thigh given.  Benadryl 25mg PO given.  Attempted 2nd Benadryl dose...unable to swallow.   EMS arrived.  Taken to ER.  Symptoms slowly improved.  Solumedrol IV given in ER.  Monitored for 2.5hrs then discharged home with Prednisone PO for 5 days.
NAUSEA, BACK ACHE, BODY ACHES, PAIN AND SORENESS
Redness and swelling of the left upper arm bicep area for one day c/o tenderness with palpation, afebrile, no redness or swelling noted at injection site.
the patient's Papanicolaou test came back positive for HPV disease; This spontaneous report was received from a medical assistant and refers to a 26-year-old female patient.  No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 17-SEP-2018, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, dose 1 (strength, frequency, route of administration, lot # and expiration date were not reported) for prevention from human papilloma virus (HPV) disease. On an unknown date, the patient experienced papilloma viral infection. The patient's Papanicolaou test came back positive for HPV disease. Action taken with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) and the outcome of the event were not reported.  Causality assessment was not provided.
Friends got the shot and caught it/Suspected vaccination failure; Caught it; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 27-Oct-2022 Reporter's comment: The case was received from the consumer via interactive digital media. The reporter reported that he/she had friends who got the shot and caught them. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. The case was linked with case US2021AMR100406, US2021AMR100411 and US2021AMR131359 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR100406:Same reporter. US-GSK-US2021AMR100411:Same reporter. US-GLAXOSMITHKLINE-US2021AMR131359:Same reporter.